Roundup trial: Plaintiff in glyphosate-cancer lawsuit asks for $18 million in damages as jury deliberations continue

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Arguing that agrochemical company Monsanto has spent decades deceiving consumers about the dangers of its popular Roundup weed killer, attorneys for a California man living with cancer asked a federal jury [March 26] to award their client $18 million for his pain and suffering….

The comment came during closing arguments in the second half of the high-stakes trial over the apparent carcinogenicity of Roundup….After deciding in an initial trial phase that Roundup partly caused plaintiff Edwin Hardeman’s non-Hodgkin lymphoma, the….jury must now decide whether Monsanto is liable for his illness and how much it must pay in damages if it is.

“Nothing has stopped this company,” plaintiff’s attorney Jennifer Moore told jurors, adding that Monsanto cares only about profits. “You’ve got to warn – no more business as usual at Monsanto. Send that message loud and clear.”

Related article:  How to change the minds of GMO skeptics

Monsanto, which German pharmaceutical company Bayer AG acquired last June, insists Roundup and its active ingredient glyphosate are safe, citing hundreds of studies finding no link between them and non-Hodgkin lymphoma….

But Hardeman, who was diagnosed with aggressive Stage 3 non-Hodgkin lymphoma in early 2015 and is now in remission, claims his 26 years using Roundup….caused the disease.

Read full, original article: Jurors Take Over in Roundup Cancer Trial Liability Phase

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend